Danaher Corporation Stock News

WASHINGTON , Jan. 2, 2024 /PRNewswire/ -- Danaher Corporation (NYSE: DHR) announced that President and Chief Executive Officer, Rainer M. Blair, will be presenting at the J.P.

This year's list is a bit more defensive than in years past and has a focus on earnings growth.

Danaher has undergone a radical transformation from a real estate trust to a leader in the life sciences industry through strategic acquisitions. The company's focus on continuous improvement and effi

Danaher is my low-risk SWAN stock pick for 2024, with a strong track record of growth and a focus on rational, data-driven decision-making at its core. The end market for Danaher's healthcare and biop

After lagging most sectors in 2023, healthcare stocks could deliver substantial returns in 2024. The market has been overly pessimistic about the sector due to short-term challenges.

WASHINGTON , Dec. 21, 2023 /PRNewswire/ -- Danaher Corporation (NYSE: DHR) announced that it will webcast its quarterly earnings conference call for the fourth quarter 2023 on Tuesday, January 30, 20

Strength in the Life Sciences segment and accretive acquisition bode well for Danaher (DHR). The company's measures to reward its shareholders are encouraging.

Danaher (DHR) closed the most recent trading day at $226.45, moving -0.34% from the previous trading session.

Danaher (DHR) concluded the recent trading session at $221.35, signifying a +1.77% move from its prior day's close.

Danaher (DHR) acquires Abcam for $5.7 billion, thus adding to its Life Sciences portfolio. This move will facilitate the mapping of complex diseases and expedite the drug discovery process.

Medical tools supplier Danaher said on Wednesday it has completed the $5.7 billion acquisition of Abcam , overcoming the initial opposition from the founder of the protein consumables maker.

The latest trading day saw Danaher (DHR) settling at $219.44, representing a -1.21% change from its previous close.

Danaher (DHR) concluded the recent trading session at $222.52, signifying a +1.72% move from its prior day's close.

Danaher Corporation (NYSE:DHR ) 6th Annual Evercore ISI HealthCONx Conference November 29, 2023 3:00 PM ET Company Participants Rainer Blair - CEO Conference Call Participants Vijay Kumar - Evercore I

Danaher Corporation is facing near-term headwinds due to COVID-19-related demand normalization and customer inventory destocking in its Biotechnology segment. However, these headwinds are temporary, a